119 related articles for article (PubMed ID: 35348117)
1. Mesenchymal Stromal Cells Inhibit Aerobic Glycolysis in Activated T Cells by Negatively Regulating Hexokinase II Activity Through PD-1/PD-L1 Interaction.
Kawasaki Y; Sato K; Mashima K; Nakano H; Ikeda T; Umino K; Morita K; Izawa J; Takayama N; Hayakawa H; Tominaga K; Endo H; Kanda Y
Transplant Cell Ther; 2021 Mar; 27(3):231.e1-231.e8. PubMed ID: 35348117
[TBL] [Abstract][Full Text] [Related]
2. Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells.
Guan Q; Li Y; Shpiruk T; Bhagwat S; Wall DA
Cytotherapy; 2018 May; 20(5):639-649. PubMed ID: 29548707
[TBL] [Abstract][Full Text] [Related]
3. IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells.
Chinnadurai R; Copland IB; Patel SR; Galipeau J
J Immunol; 2014 Feb; 192(4):1491-501. PubMed ID: 24403533
[TBL] [Abstract][Full Text] [Related]
4. Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer.
Kim S; Jang JY; Koh J; Kwon D; Kim YA; Paeng JC; Ock CY; Keam B; Kim M; Kim TM; Heo DS; Chung DH; Jeon YK
J Exp Clin Cancer Res; 2019 Nov; 38(1):462. PubMed ID: 31718692
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine 2,3-dioxygenase mediates inhibition of virus-specific CD8(+) T cell proliferation by human mesenchymal stromal cells.
Hong J; Hueckelhoven A; Wang L; Schmitt A; Wuchter P; Tabarkiewicz J; Kleist C; Bieback K; Ho AD; Schmitt M
Cytotherapy; 2016 May; 18(5):621-9. PubMed ID: 27008974
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stromal Cells Disrupt mTOR-Signaling and Aerobic Glycolysis During T-Cell Activation.
Böttcher M; Hofmann AD; Bruns H; Haibach M; Loschinski R; Saul D; Mackensen A; Le Blanc K; Jitschin R; Mougiakakos D
Stem Cells; 2016 Feb; 34(2):516-21. PubMed ID: 26485560
[TBL] [Abstract][Full Text] [Related]
7. Suppression of IL-10 production by activated B cells via a cell contact-dependent cyclooxygenase-2 pathway upregulated in IFN-γ-treated mesenchymal stem cells.
Hermankova B; Zajicova A; Javorkova E; Chudickova M; Trosan P; Hajkova M; Krulova M; Holan V
Immunobiology; 2016 Feb; 221(2):129-36. PubMed ID: 26416211
[TBL] [Abstract][Full Text] [Related]
8. Glycolytic enzyme HK2 promotes PD-L1 expression and breast cancer cell immune evasion.
Lin J; Fang W; Xiang Z; Wang Q; Cheng H; Chen S; Fang J; Liu J; Wang Q; Lu Z; Ma L
Front Immunol; 2023; 14():1189953. PubMed ID: 37377974
[TBL] [Abstract][Full Text] [Related]
9. Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality.
Saha A; Aoyama K; Taylor PA; Koehn BH; Veenstra RG; Panoskaltsis-Mortari A; Munn DH; Murphy WJ; Azuma M; Yagita H; Fife BT; Sayegh MH; Najafian N; Socie G; Ahmed R; Freeman GJ; Sharpe AH; Blazar BR
Blood; 2013 Oct; 122(17):3062-73. PubMed ID: 24030385
[TBL] [Abstract][Full Text] [Related]
10. Adenosine increases PD-L1 expression in mesenchymal stromal cells derived from cervical cancer through its interaction with A
Marín-Aquino LA; Mora-García ML; Moreno-Lafont MC; García-Rocha R; Montesinos-Montesinos JJ; López-Santiago R; Sánchez-Torres LE; Torres-Pineda DB; Weiss-Steider B; Hernández-Montes J; Don-López CA; Monroy-García A
Cell Biochem Funct; 2024 Apr; 42(3):e4010. PubMed ID: 38613217
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression.
Davies LC; Heldring N; Kadri N; Le Blanc K
Stem Cells; 2017 Mar; 35(3):766-776. PubMed ID: 27671847
[TBL] [Abstract][Full Text] [Related]
12. Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing.
Chinnadurai R; Copland IB; Garcia MA; Petersen CT; Lewis CN; Waller EK; Kirk AD; Galipeau J
Stem Cells; 2016 Sep; 34(9):2429-42. PubMed ID: 27299362
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells increase skin graft survival time and up-regulate PD-L1 expression in splenocytes of mice.
Moravej A; Geramizadeh B; Azarpira N; Zarnani AH; Yaghobi R; Kalani M; Khosravi M; Kouhpayeh A; Karimi MH
Immunol Lett; 2017 Feb; 182():39-49. PubMed ID: 28069488
[TBL] [Abstract][Full Text] [Related]
14. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.
Meisel R; Zibert A; Laryea M; Göbel U; Däubener W; Dilloo D
Blood; 2004 Jun; 103(12):4619-21. PubMed ID: 15001472
[TBL] [Abstract][Full Text] [Related]
15. Tonsil-derived mesenchymal stem cells (T-MSCs) prevent Th17-mediated autoimmune response via regulation of the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway.
Kim JY; Park M; Kim YH; Ryu KH; Lee KH; Cho KA; Woo SY
J Tissue Eng Regen Med; 2018 Feb; 12(2):e1022-e1033. PubMed ID: 28107610
[TBL] [Abstract][Full Text] [Related]
16. Combination therapies enhance immunoregulatory properties of MIAMI cells.
Rossi F; Noren H; Sarria L; Schiller PC; Nathanson L; Beljanski V
Stem Cell Res Ther; 2019 Dec; 10(1):395. PubMed ID: 31852519
[TBL] [Abstract][Full Text] [Related]
17. The Immunomodulatory Effect of Triptolide on Mesenchymal Stromal Cells.
He H; Takahashi A; Mukai T; Hori A; Narita M; Tojo A; Yang T; Nagamura-Inoue T
Front Immunol; 2021; 12():686356. PubMed ID: 34484183
[TBL] [Abstract][Full Text] [Related]
18. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
Front Immunol; 2018; 9():1125. PubMed ID: 29910803
[TBL] [Abstract][Full Text] [Related]
19. Activated Mesenchymal Stromal Cells Process and Present Antigens Regulating Adaptive Immunity.
van Megen KM; van 't Wout ET; Lages Motta J; Dekker B; Nikolic T; Roep BO
Front Immunol; 2019; 10():694. PubMed ID: 31001285
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular Carcinoma Cells Are Protected From Immunolysis by Mesenchymal Stromal Cells Through Indoleamine 2,3 Dioxygenase.
Chinnadurai R; Porter AP; Patel M; Lipat AJ; Forsberg MH; Rajan D; Hematti P; Capitini CM; Bruker C
Front Cell Dev Biol; 2021; 9():715905. PubMed ID: 34869307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
